Competition record
Zelis
Deep profile · 1 linked library matter
Zelis reprices out-of-network medical bills and, doctors say, is paid a share of the savings. A Massachusetts court let the claims proceed, dismissed Aetna in September 2026, and discovery runs toward March 2027.
Overview
Zelis reviews a bill from a doctor who is outside the patient's network and offers a lower number, keeping a commission that doctors describe as a share of the difference. Insurers are the clients, and physicians are the ones whose charges get cut.
Doctors allege that insurers pooled confidential rate data through that repricing. A Massachusetts court let the claims proceed and dismissed Aetna in September 2026.
Discovery is aimed at March 2027, and a trial has been discussed for 2028. Letting the claims proceed is not a verdict, and the 2028 date is a discussion rather than a judgment.
Competition footprint
The alleged commission is a share of the savings off the physician's bill, so a deeper cut can mean a larger fee.
Pooling confidential insurer data is the doctors' theory of how those repriced amounts were set.
Aetna's dismissal in September 2026 removed that insurer and left the rest of the case going.
Consumer & business angle
Physicians who bill out of network are the plaintiffs, and patients may still owe the repriced balance.
Insurers other than Aetna remain the alleged sources of the confidential data.
What to watch
- Discovery as it runs toward March 2027.
- Whether the discussed 2028 trial receives a date.
Markets
out-of-network medical bill repricing · out-of-network health payments
Also known as: zelis